- ￥415
- Genwaybio
- 美国
- GWB-AC1360
- 2025年07月07日
- 详见官方网站
- 详见官方网站
- 详见说明书
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
详见官方网站
- 亚型：
详见官方网站
- 形态：
冻干粉/浓缩液
- 保存条件：
-20℃
- 克隆性：
多克隆
- 标记物：
详见说明书
- 适应物种：
详见说明书
- 宿主：
详见官方网站
- 应用范围：
详见官方网站
- 浓度：
1mg/ml
- 抗体英文名：
Yeast Cytosine Deaminase Antibody
- 规格：
100ug，200ug，1mg
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Clinical Trials With GDEPT: Cytosine Deaminase and 5-Fluorocytosine
. Several combinations have been described for GDEPT, one of these being the cytosine deaminase/5-fluorocytosine system. Cytosine deaminase (CD) is a nonmammalian enzyme that catalyses the hydrolytic deamination of cytosine to uracil. Therefore, it is capable
Intratumoral Gene Transfer of the Cytosine Deaminase Gene for the Treatment of Breast Cancer
and neoplastic cells to drive the selective expression of a metabolic suicide gene able to convert a nontoxic prodrug into its toxic metabolite. Genetically modified cells that express the nonmammalian enzyme cytosine deaminase (CD) gene are able to convert
Surgery, radiation therapy, and chemotherapy have been applied to the curative therapy of 50% of cancer patients in the United States during the past 100 years. It is clear that the chemotherapeutic agents used to develop curative therapy
技术资料暂无技术资料 索取技术资料
